emis

Novo Nordisk Inks Insulin Pill Development Pact with Emisphe

Published on Tue, 12/21/2010 - 12:55
By FNN Staff in General Interest, emis, nvo, adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech
adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech

Novo Nordisk (NVO) ADRs are down after the company said it had signed a deal with Emisphere Technologies (EMIS) to use that firm's technology to develop an oral insulin pill, according to a company statement. Currently, there are

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Zale: The Winning Streak Continues (ZLC)...

Zale (NYSE:ZLC) traded today at a new 52-week high of $9.57. This new high was reached ...

Shares of WMS Industries Rise Above Prev...

Shares of WMS Industries (NYSE:WMS) traded at a new 52-week high today of $25.62. This ...

Wright Medical Looks to Continue to Trad...

Wright Medical (NASDAQ:WMGI) traded today at a new 52-week high of $25.51. This new hi ...

Walter Energy: The Losing Streak Continu...

Walter Energy (NYSE:WLT) traded today at a new 52-week low of $11.16. This new low was ...

Waste Connections: The Winning Streak Co...

Shares of Waste Connections (NYSE:WCN) traded today at $41.15, breaking its 52-week hig ...

Waters: The Winning Streak Continues (WA...

Waters (NYSE:WAT) traded today at a new 52-week high of $100.56. So far today approxim ...

Recent 52-Week High Exceeded in Shares o...

Shares of Umpqua Holdings (NASDAQ:UMPQ) traded today at $14.46, breaking its 52-week hi ...

Monotype Imaging Holdings: 52-Week High ...

Monotype Imaging Holdings (NASDAQ:TYPE) traded today at a new 52-week high of $24.59. ...

Most Popular Video News